Mastering the Move from Phase III to Launch

Penny Wills

Penny Wills

Senior Director Implementation, J+D Forecasting

Published

Share:

Mastering the Move from Phase III to Launch

Penny Wills

Penny Wills

Senior Director Implementation, J+D Forecasting

Published

Share:

The journey from Phase III clinical trials to a successful product launch is both exciting and challenging. It’s a crucial stage that sets the foundation for how a new product will perform in the market. But with resources often already allocated to established brands, and the need for precise forecasting and planning, launching a new product can feel like a balancing act. How do you ensure your team is prepared for a smooth transition?

Our webinar tackles exactly these challenges, offering real-world insights and strategies to help professionals make the leap from Phase III to launch with confidence. During the webinar, we’ll focus on three key areas:

  1. Transitioning forecast models across product stages: How can you evolve your models as your product progresses through the lifecycle?
  2. Resource Allocation and Shift Management: When and how do you know when to shift resources between brand and products – without disrupting the rest of your portfolio?
  3. Data Demands and Requirements: Data needs are never static, so we’ll discuss how to use data effectively to make smarter decisions.

Why This Matters Now
For pharma companies, the stakes are high. A successful product launch can create lasting brand loyalty and drive growth, while a misstep at this stage can have long-term consequences. As product pipelines grow and the industry becomes increasingly competitive, understanding how to navigate the launch phase has never been more important.

Hear from Product Launch Experts
Joining me on the panel are seasoned industry professionals who have firsthand experience in pharma launch excellence. Together, we’ll share insights on best practices plus pitfalls to avoid, offering actionable advice for making your launch a success.

Whether you’re directly involved in forecasting, marketing, or commercial operations, this webinar will provide valuable takeaways to help you steer your next product launch in the right direction.

Thursday 21 November 3pm GMT | 10am EST
Catch up on-demand!

Upcoming Webinar

World Preview 2026

Tuesday 16th June 2026 | 3pm BST

By 2032, the global pharmaceutical market is forecast to reach almost $1.9tn. Inside the innovations, dealmaking, and portfolio strategies transforming the global biopharma pipeline.

Related Content